Parenting Skills Program to Help Children With Leukemia Take Medicines
Tests a parenting skills program to help children with leukemia take their medicines.
Key facts
- Who runs it
- Roswell Park Cancer Institute
- Where
- Buffalo, United StatesSee the site
- Trial code
- Registry title
- Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 7 Nov 2024
- Expected to end
- 1 Oct 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- CareMeds Intervention
- Usual Care Group
- Record updated
- 23 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for parents who manage the medicine of a child aged 3-9 years with acute lymphoblastic leukemia (ALL) taking oral cancer medicine at home.
- Age
- The child must be 3-9 years old.
- Sex
- Children of any sex can join.
- Disease stage
- The child has any type of acute lymphoblastic leukemia (ALL) and is being treated at a study site.
- Earlier treatment
- The child is on treatment that includes oral anti-cancer medicine taken at home, such as 6-MP.
Main reasons for not taking part
- Parent does not have main responsibility for the child's medicine
- Parent does not speak English or Spanish
- Parent is unwilling or unable to follow the trial's requirements
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site
- Parent has primary medication responsibility
- Pediatric patient aged 3-9 years
- Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP
- Parent has verbal English or Spanish fluency
- Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Who cannot take part
- Parent is unwilling or unable to follow protocol requirements
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 9 years old?
Where in United States
- Roswell Park Comprehensive Cancer CenterBuffalo, United StatesContact: Elizabeth Bouchard, MDTaking people
About the trial
What the trial wants to find out
The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.
The 2 groups in the trial
- CareMeds InterventionTreatment being tested
Participants complete the CareMeds parent training sessions during weeks 2, 3 and 4.
- Usual CareExisting treatment, for comparison
Usual care consists of medical consultations and supportive care, The usual care group will serve as a delayed intervention/wait list group for which 3 parent training sessions will be offered during weeks 13 through 15.
Treatment: Usual Care Group
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
- Plain-language title
- Parenting Skills Program to Help Children With Leukemia Take MedicinesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06074666, who can take part
- Record updated
- 23 April 2026